GlassScriptPhysician profile
Mohammed A Islam
NPI 1255330569
$3,603.85
in general payments reported to CMS, 2019-2025
19 companies · $1,370 in 2025
The $1,370 reported for 2025 was more than what 77% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2020: $31.00 · 2021: $366 · 2022: $533 · 2023: $680 · 2024: $454 · 2025: $1,370.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,751 · Travel and Lodging: $753.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,750.50 |
| Travel and Lodging | $753.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,236.98 | 2021-2025 | Aveir, Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Boston Scientific Corporation | $450.81 | 2021-2025 | Watchman Flx, Watchman Access System, Lux-Dx Insertable Cardiac Monitor |
| Merck Sharp & Dohme LLC | $431.18 | 2021-2025 | Verquvo |
| Medtronic, INC. | $409.36 | 2021-2025 | Na, Azure Xt Dr Mri Surescan, Linq II |
| E.R. Squibb & Sons, L.L.C. | $242.85 | 2021-2025 | Eliquis, Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $220.71 | 2024-2025 | Lifevest |
| Pfizer INC. | $108.92 | 2021-2024 | |
| Sanofi-Aventis U.S. LLC | $97.84 | 2019 | |
| Janssen Pharmaceuticals, INC | $91.81 | 2021-2023 | Xarelto |
| Amgen INC. | $77.01 | 2019-2024 | Repatha |
| Actelion Pharmaceuticals US, INC. | $53.51 | 2023 | Opsumit, Uptravi |
| Kestra Medical Technology Services, INC. | $39.81 | 2025 | Assure Wcd |
| Cardiva Medical, INC. | $31.45 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Octapharma USA, INC. | $28.66 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.72 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $19.73 | 2020 | |
| Scpharmaceuticals INC. | $16.87 | 2025 | |
| Astellas Pharma US INC | $13.36 | 2019 | |
| Siemens Medical Solutions USA, INC. | $11.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammed Islam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.